A Breakthrough in Dialysis Access ST. LOUIS, Jan. 13, 2026 /PRNewswire/ -- Amplifi Vascular, Inc., has been granted Breakthrough Device Designation and Category B assignment from the Centers for Medicare & Medicaid Services (CMS) for the Amplifi Vein Dilation System. This significant...
Hence then, the article about amplifi vascular gains fda breakthrough device status cms category b was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Amplifi Vascular Gains FDA Breakthrough Device Status & CMS Category B )
Also on site :
- Arden University and Google Cloud Form Strategic Partnership to Ensure Development of Job-Ready, AI-Native Graduates
- Exclusivo: ordenan a ICE aumentar las detenciones diarias de inmigrantes a pesar del malestar del Partido Republicano
- ‘Below’ Review: Josh Hartnett Battles a Sea Creature in Netflix’s Likably Silly Newfoundland-Set Thriller